Trailing Twelve Months Revenue Growth: Nuvation Corp (NUVB)

Public company logo of nuvationbio.com (NUVB)

The high barrier to entry in the oncology business, driven by colossal costs and patent protection, makes Nuvation Bio Inc. (NUVB) a promising asset. The year-over-year revenue change over the trailing twelve months (TTM) visualizes this potential, where 656.00 shows the value of this parameter. Flexible raw material supply chains ensure stability, while investor confidence is bolstered by the effective merger of new biotechnological units under management control.

Nuvation Bio Inc. (NUVB): Revenue Growth YoY (Last 12 Months) from 02/11/2024 to 11/18/2026

Nuvation Bio Inc. - analytical breakdowns and key metrics (NUVB)

- stock price and consensus target price:
- company stock exchange capitalization indicators:
Summary company analytics:Nuvation Pharma
Brand item of Nuvation Corp

To objectively evaluate Nuvation Bio Inc. (NUVB), a manager requires an analysis of trailing twelve-month revenue dynamics, measuring the daily rate of change in operating income to determine the stability of the business trajectory. By analyzing the year-over-year revenue growth trend over a rolling year, an investor can identify risks of slowing expansion caused by geopolitical disruptions in component supplies or complexities regarding international patent protection.

Who Nuvation Bio Inc. competes with

Incyte Pharma - Sales Growth YoY (Last Twelve Months)|HUTCHMED Corp - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Day One|MNPR: Sales Growth YoY (TTM)|Revenue Growth Rate YoY (Last Twelve Months) Inhibrx Biosciences Inc INBX|Revenue Growth YoY (Last 12 Months) IMAB|Trailing Twelve Months Revenue Growth Fennec Pharmaceuticals FENC|Revenue Growth YoY (Last 12 Months) HRTX (Heron)|NVCT (Nuvectis Pharma) - Revenue Dynamics YoY (Last Twelve Months)|Coherus Biosciences - Revenue Growth YoY (Last 12 Months)|Revenue Change YoY (Last 12 Months) CRBP (Corbus Pharmaceuticals Holdings)|Cardiff Oncology - Sales Growth YoY (TTM)|Revenue Dynamics YoY (Last Twelve Months) BYSI (BeyondSpring Pharma)|BCAB: Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth lixte.com (LIXT)|Sales Growth YoY (Last Twelve Months) citiuspharma.com|CLRB: Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (TTM) BLRX|Sales Growth YoY (TTM) Can-Fite (CANF)|Sales Growth YoY (Last Twelve Months) Aprea Therapeutics Inc. APRE|KZIA (kaziatherapeutics.com) - Trailing Twelve Months Sales Growth|SLXN: Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Revenue Growth NuCana|CMRX: Sales Growth YoY (TTM)|Revenue Growth YoY (Last 12 Months) Cyclacel Pharmaceuticals|GTHX (g1therapeutics.com) - Sales Growth YoY (TTM)|KRON: Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Kintara (KTRA)|Revenue Growth YoY (Last 12 Months) Oncternal ONCT|Portage Biotech - Revenue Growth YoY (Last 12 Months)